Thyroid disease is a favorable prognostic factor in achieving sustained virologic response in chronic hepatitis C undergoing combination therapy: A nested case control study
Open Access
- 24 May 2011
- journal article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 11 (1) , 10
Abstract
Interferon-α in combination with ribavirin is the current gold standard for treatment of chronic hepatitis C. It is unknown if the development of autoimmune thyroid disease (TD) during treatment confers an improved chance of achieving sustained virologic response. The aim of this study is to assess the chance of achieving sustained virologic response (SVR) in patients who developed TD during treatment when compared with those who did not.Keywords
This publication has 28 references indexed in Scilit:
- Immune Response of Cytotoxic T Lymphocytes and Possibility of Vaccine Development for Hepatitis C Virus InfectionJournal of Biomedicine and Biotechnology, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistenceJournal of Clinical Investigation, 2009
- Diagnosis, management, and treatment of hepatitis C: An update # † ‡Hepatology, 2009
- The natural history of interferon- 2b-induced thyroiditis and its exclusivity in a cohort of patients with chronic hepatitis C infectionQJM: An International Journal of Medicine, 2008
- Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-α therapy for hepatitis C virus-related hepatitisEuropean Journal of Endocrinology, 2007
- Treating viral hepatitis C: efficacy, side effects, and complicationsGut, 2006
- Diagnosis and treatment of chronic hepatitis C infectionBMJ, 2006
- Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: Incidence, associated factors and prognosis.Journal of Gastroenterology and Hepatology, 2006
- Global epidemiology of hepatitis C virus infectionThe Lancet Infectious Diseases, 2005